Introduction
============

In the human endometrium, uterine leukocytes undergo cyclic changes in cell number during the menstrual cycle. Uterine natural killer (uNK) cells comprise 70% of all decidual leukocytes during the secretory phase, when implantation occurs, and during early pregnancy ([@b1-mmr-10-06-2851],[@b2-mmr-10-06-2851]). At the initiation of embryo implantation and placentation, uNK cells interact with the extravillous trophoblasts and fetal cells that invade the uterus, where they remove and replace the smooth muscle of maternal spiral arteries ([@b3-mmr-10-06-2851]). This ultimately converts small, coiled vessels into wider channels that are able to provide nutrients to the developing fetus ([@b4-mmr-10-06-2851]).

The initial contact between the blastocyst and uterus occurs through adhesion of the embryonic trophectoderm to the uterine epithelium ([@b5-mmr-10-06-2851]). During implantation, the epithelium is said to become 'receptive' ([@b6-mmr-10-06-2851]). In addition, the transformation of endometrial stromal cells from small, densely packed cells to large polygonal cells with an open vesicular nucleus is one of the characteristic features of decidualization ([@b7-mmr-10-06-2851]). These findings suggest that endometrial epithelial and stromal cells are important in implantation and decidualization. Furthermore, a previous study demonstrated that epithelial STAT3 controlled stromal function via a paracrine mechanism ([@b8-mmr-10-06-2851]), indicating that there is epithelial-stromal crosstalk during implantation.

Implantation marks a transition stage in pregnancy, in which the blastocyst assumes a fixed position and establishes an altered physiological interaction with the uterus. The paracrine effects of uNK cells stimulate stromal fibroblasts to produce chemokines and cytokines, which support trophoblast migration during implantation. They also upregulate interleukin (IL)-15 and IL-15Rα in stromal fibroblasts that may establish an environment for uNK cells to promote cell proliferation and recruitment into the uterus ([@b9-mmr-10-06-2851]). There is strong evidence that implantation and early pregnancy are not a single event, and do not occur simultaneously ([@b10-mmr-10-06-2851]). Thus, in order to investigate the effects of uNK cell paracrine signaling on these processes as a whole, a co-culture system consisting of epithelial and stromal cells was created. Furthermore, the regulation of trophoblast invasion and modification of the spiral arteries, was investigated ([@b11-mmr-10-06-2851]).

Materials and methods
=====================

Ethical approval
----------------

All subjects understood and signed the informed consent form prior to participation. Experimental protocols were approved by the Ethics Committee of the Dongfang Hospital Human Ethics Committee, Beijing, China (no. 2011090201).

Tissue collection
-----------------

Decidual tissues were obtained from ten healthy females undergoing an elective termination of a normal pregnancy at between seven and eight weeks of gestation, as determined by the last menstrual period.

Endometrial tissues were collected from biopsies taken during the proliferative phase of the menstrual cycle of females undergoing laparoscopy for benign disease (Dongfang Hospital of Beijing University of Chinese Medicine, Beijing, China). The exclusion criteria were hormonal stimulation, cancerous lesions and irregular menstrual bleeding. There were six volunteers and two endometrial biopsies per volunteer were obtained. Samples from three of the females (six biopsies) were used for the for microarray experiments and samples from the remaining three females (six biopsies) were used for the reverse transcription-quantitative polymerase chain reaction and enzyme-linked immunosorbent assay experiments. Of the two samples taken from each patient, one sample was used as a control and the other was used in the experimental group.

uNK cell isolation
------------------

uNK cells were purified as previously described ([@b2-mmr-10-06-2851]). Briefly, decidual tissues were thoroughly washed with Ca^2+^- and Mg^2+^-free Hank's balanced salt solution (HBSS) containing 100 U/ml penicillin and 100 g/ml streptomycin (Sigma-Aldrich, St. Louis, MO, USA), cut into fragments of 1--2 mm^3^ using two scalpels and digested for 1 h at 37°C with gentle agitation in HBSS with 0.1% (w/v) collagenase I (Gibco-BRL, Carlsbad, CA, USA). Cell suspensions were layered over Ficoll-Hypaque medium (General Electric, Fairfield, CT, USA) and centrifuged at 800 × g for 25 min. Cells at the interface were washed twice in RPMI-1640 media with 10% fetal calf serum (FCS) and antibiotics. Following incubation for 20 min at 4°C with anti-CD56 micro beads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), cells were washed in washing buffer \[phosphate-buffered saline (PBS), EDTA 2 mM and 0.5% bovine serum albumin(w/v)\] and loaded onto a manual cell separation (MS) column in a MiniMACS magnet (MiniMACS^TM^ Separator System; Miltenyi Biotec GmbH). The MS column was flushed three times and CD56^+^ cells were flushed according to the manufacturer's instructions. The purity of the uNK cells was \>90% CD56^+^CD3^−^ according to flow cytometric analysis. The uNK cells were cultured in RPMI-1640 media with 1% FCS and 10 ng/ml IL-15 (R&D Systems Inc., Minneapolis, MN, USA).

uNK cell-secretion medium production
------------------------------------

uNK cell-secretion medium was prepared using 200 μl RPMI-1640 media with 1% FCS and IL-15 (10 ng/ml) containing 5×10^5^ of the purified uNK cells and placed into the upper chamber of a 0.4-μm pore hanging cell culture insert (EMD Millipore, Billerica, MA, USA) in a 24-well tissue plate, with 1,300 μl of the same media excluding cells in the lower chamber. Germeyer *et al* ([@b9-mmr-10-06-2851]) showed that soluble factors from uterine leucocytes had significant effects on endometrial cell gene expression. Thus, a hanging cell culture insert was used so that soluble molecules from the uNK cells were able pass through the filter into the lower chamber, without cells being in direct contact. The control medium comprised 1,500 μl RPMI-1640 media with 1% FCS and 10 ng/ml IL-15. This was used for subsequent experiments. Following incubation for 24 h at 37°C, the uNK cell-secretion medium from the lower chamber and the control media were collected. To reduce interassay variability, the media from several batches was pooled for subsequent experiments and frozen at −80°C. Cells in the upper chamber were collected and the cell viability was measured using a live/dead viability kit (Invitrogen Life Technologies, Carlsbad, CA, USA). Only uNK cell samples containing \<35% of dead cells following overnight incubation were used for subsequent experiments.

Endometrial stromal and epithelial cell isolation
-------------------------------------------------

Human endometrial tissue was dissociated into single cells using 0.1% (w/v) collagenase I (Life Technologies, Carlsbad, CA, USA) for 50--60 min at 37°C. Cell suspensions were filtered using a 40-μm sieve to separate undigested myometrial tissue and debris. Further dissociation of the filtrate was prevented by Dulbecco's modified Eagle's medium (DMEM)/F-12 (no Phenol Red; Gibco-BRL) with 10% FBS (Gibco-BRL). To remove erythrocytes, the cells were resuspended in 4 ml DMEM/F12 with 1% FCS, layered over Ficoll-Paque PLUS (General Electric) and centrifuged for 25 min at 800 × g. Endometrial cells were removed from the Ficoll-Paque PLUS medium interface, washed three times and resuspended in 1 ml DMEM/F12 with 1% FCS. Leukocytes were removed with CD45-coated Dynabeads (Invitrogen Life Technologies). Purified stromal and epithelial cell suspensions were then obtained by a further round of magnetic bead sorting using Collection Epithelial Enrich Dynabeads (Invitrogen Life Technologies). Epithelial and stromal cell preparations were \>95% pure.

Stromal cells were cultured in DMEM/F12 with 10% FBS and an antibiotic-antimycotic agent (100 U/ml penicillin, 100 g/ml streptomycin, 10 μg/ml gentamicin 0.25 μg/ml amphotericin B; Life Technologies). Epithelial cells were cultured in serum-free bronchial epithelial cell growth medium (final volumes: 2 ml bovine pituitary extract, 0.5 ml insulin, 0.5 ml HC, 0.5 ml GA-1000, 0.5 ml retinoic acid, 0.5 ml transferrin, 0.5 ml triiodothyronine, 0.5 ml epinephrine and 0.5 ml hEGF; Lonza, Walkersville, MD, USA) and an antibiotic-antimycotic agent. The isolated stromal and epithelial cells were separately seeded into six-well plates with 3 ml culture medium per well. Each well contained stromal or epithelial cells from a single patient. After two weeks, cells were passaged into 25 cm^2^ cell culture flasks. Following this, stromal cells were passaged every 4--5 days and epithelial cells were passaged every 9--10 days.

Co-culture system
-----------------

On day 20 following endometrial stromal and epithelial cell generation, cells of each type were seeded onto a Nunc UpCell Surface membrane (Thermo Labsystems, Santa Rosa, CA, USA). The co-culture system was built on these temperature-responsive cell culture surfaces, according to the manufacturer's instructions. In brief, when cells reached 80% confluence, all medium was aspirated and 500 μl fresh medium was added. The membrane was then placed on top of the stromal cell layer. The Nunc UpCell Surface was maintained at 20°C for 13 min. The membrane and cell layer were then carefully removed from the Nunc UpCell Surface using forceps. The membrane with the attached cell layer was transferred facing downwards onto the epithelial cell surface. Fresh medium was added and samples were incubated at 37°C for 40 min. A further 1 ml of medium was added to the top of the membrane and the membrane was withdrawn from the cell layer. The ratio of stromal to epithelial cells was 1:1, and every co-culture system was built using stromal and epithelial cells from the same participant. Co-cultured cells were maintained in DMEM/F12 with 1% FCS.

Co-culture system treatment
---------------------------

Each group, control and uNK cell, contained six co-culture systems. All the groups were washed twice with PBS and placed in serum-free DMEM for 16 h prior to subsequent experiments. DMEM was replaced by 80% uNK cell-secretion medium and 20% DMEM in the uNK cell group, whilst the control group was treated with 80% control medium and 20% DMEM. Following incubation for 6 h, the cells and media from each group were collected. Three pairs of co-culture systems were used for the microarray studies and three pairs for the RT-qPCR experiments.

Microarray experiments
----------------------

Total RNA was extracted from the endometrial cells in each co-culture system. RNA was purified with the RNeasy Mini kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. The microarray analysis was performed using the GeneChip^®^ 3′ IVT Express kit (Affymetrix Inc., Santa Clara, CA, USA). Briefly, total RNA underwent reverse transcription, first strand cDNA synthesis, double strand DNA, *in vitro* transcription, cRNA synthesis and fragmentation ([@b12-mmr-10-06-2851]). Samples were hybridized onto GeneChip PrimeView Human Gene Expression Array (Affymetrix Inc.). This array covers \>36,000 transcripts and variants. Following 16 h hybridization at 45°C, arrays were washed on Fluidics Station 450 (Affymetrix, Inc.) and were scanned with Scanner 3000 (Affymetrix, Inc.) in order to obtain quantitative gene expression levels. The control and uNK cell groups were processed simultaneously throughout. Three chips were analyzed for each group.

RT-qPCR analysis
----------------

A total of four differentially expressed genes were selected for validation of the results from the microarray experiments using RT-qPCR. Cells from the control and uNK cell groups were washed twice with PBS, and total RNA was extracted using TRIzol (Life Technologies). Reverse transcription was performed with 8 μl of total RNA per 20 μl reaction using a standard cDNA Synthesis kit (Takara Bio, Inc., Otsu, Japan). The RT-qPCR primer sequences for target genes were self-designed by this group and ordered from Invitrogen. Primer sequences for target genes are shown in [Table I](#tI-mmr-10-06-2851){ref-type="table"}.

For each RT-qPCR experiment, the typical thermal cycling conditions included an initial activation step at 95°C for 5 min, 40 cycles at 95°C each for 30 sec, 56°C for 20 sec and 72°C for 30 sec. PCR reactions were performed on ABI Prism 7700 Sequence Detection system (Applied Biosystems Life Technologies, Foster City, CA, USA). cDNA concentration was normalized to that of GAPDH. The target mRNA expression was analyzed using the 2^−ΔΔCt^ algorithm.

ELISA experiments
-----------------

IL-15 was analyzed using a commercially available ELISA kit (ELH-IL-15, RayBiotech, China) in the uNK cell-secretion medium prior to its use in the co-culture system experiments and in supernatants of the co-culture systems that had been treated with control media or with uNK cell-secretion medium. The analysis was conducted according to the manufacturer's instructions. Assays were performed in triplicate and concentrations of IL-15 (pg/ml) were compared with standard curves. To determine the quantities of IL-15 secreted by the co-culture systems, the starting IL-15 content of the uNK cell-secretion medium was subtracted. The sensitivity of the kit was 10 pg/ml.

Statistical analysis
--------------------

Data were analyzed using analysis of variance using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). In the microarray experiments, median fold change ratios between the control and uNK cell groups were derived for each transcript, and genes that were up- or downregulated with a fold change \>1 and P\<0.001 were selected. In RT-qPCR and ELISA analysis, data are presented as the median ± standard error of the mean. P\<0.01 was considered to indicate a statistically significant difference. Graphs of the data were produced using Microsoft Excel software.

Results
=======

Microarray experiments
----------------------

Gene expression profiling using a microarray was used to compare transcript expression in the endometrial co-culture systems treated with either control medium or uNK cell-secretion medium.

This analysis identified 155 upregulated genes that exhibited a change of \>2-fold in the median expression level in response to uNK cell-secretion medium. No transcript was downregulated \>2-fold ([Table II](#tII-mmr-10-06-2851){ref-type="table"}). However, certain genes in uNK cell groups were upregulated with a 1.0--2.0-fold change, compared with the control group. Previous studies have shown that these genes have an important functions in uNK cells. For instance, the co-culture system treated with uNK cell-secretion medium showed increased expression of interleukin (IL)15RA (1.6-fold) ([@b13-mmr-10-06-2851]), vascular endothelial growth factor (VEGF)-C (1.35-fold) ([@b14-mmr-10-06-2851]), intercellular adhesion molucule (ICAM) 1 (1.66-fold) ([@b15-mmr-10-06-2851]), superoxide dismutase (SOD)2 (1.09-fold), caspase (CASP)1 (1.85-fold), nuclear factor erythroid 2-related factor 3 (NFE2L3) (1.37-fold), interferon γ receptor 1 (IFNGR1; 1.10-fold) ([@b16-mmr-10-06-2851]), major histocompatibility complex (MHC) class I polypeptide-related sequence A (1.12-fold) and MHC class I polypeptide-related sequence B (1.34-fold) ([@b3-mmr-10-06-2851],[@b17-mmr-10-06-2851]) and showed decreased expression of IGFBP3 (1.04-fold) (P\<0.001).

RT-qPCR analysis
----------------

In order to verify these changes, transcript levels for certain genes were measured by RT-qPCR, including chemokine (C-X-C) motif ligand (CXCL)10, CXCL11, IL-15 and sterile α motif domain containing 9-like (SAMD9L; [Fig. 1](#f1-mmr-10-06-2851){ref-type="fig"}). The RT-qPCR results confirmed the significant changes in expression that had been indicated by the microarray analysis. The endometrial co-culture system treated with uNK cell-secretion medium showed increased expression of CXCL10 (16.4-fold), CXCL11 (4.3-fold), IL-15 (3.1-fold) and SAMD9L (5.4-fold; P\<0.01).

ELISA experiments
-----------------

To confirm the observed changes in the IL-15 protein level, the quantity of IL-15 was analyzed by ELISA in the supernatant of the control and uNK cell-secretion medium-stimulated endometrial co-culture systems. There was a significant increase in IL-15 protein levels in the experimental groups compared with the control group ([Fig. 2](#f2-mmr-10-06-2851){ref-type="fig"}; P\<0.01).

Discussion
==========

Several observations suggest that uNK cells are involved in reproduction. They increase in number during the luteal period of the menstrual cycle when implantation occurs ([@b1-mmr-10-06-2851]). They are present in the early phases of gestation, when placental cells invade into the maternal arteries ([@b18-mmr-10-06-2851]). In addition, they are particularly abundant in the area surrounding the infiltrating fetally derived extravillous cells ([@b19-mmr-10-06-2851]). During the progesterone-dominated phase of the menstrual cycle, uNK cells show changes in the levels of transcripts for VEGF-C ([@b20-mmr-10-06-2851]). Previous protein array studies have shown that uNK cells are the predominant producers of angiogenic growth factors in early pregnancy ([@b21-mmr-10-06-2851]). In addition, in an *ex vivo* chorionic plate artery model, uNK cells promoted vessel-like assembly of extravillous cytotrophoblast cell lines ([@b15-mmr-10-06-2851],[@b22-mmr-10-06-2851]). Insufficient uNK cell activation may reduce these processes and contribute to poor arterial remodeling in decidua, thus increasing the risk of preeclampsia and intrauterine fetal growth restriction ([@b23-mmr-10-06-2851]).

In humans, CD56^+^ NK cells are associated with the synthesis of immunoregulatory cytokines, particularly IFN-γ ([@b24-mmr-10-06-2851]). IFN-γ significantly upregulates certain chemokines \[CXCL9, CXCL10, chemokine (C-C motif) ligand 8 and IL-15Rα\], enzymes \[guanylate binding protein 5, transporter associated with antigen processing (TAP1), SOD2 and CASP1\] and transcription factors (interferon regulatory factor 1, NFE2L3 and transcription factor AP-2 γ). It is also known to downregulate insulin-like growth factor binding proteins (Wnt1 inducible signaling pathway 2 and insulin-like growth factor-binding protein 3) ([@b16-mmr-10-06-2851]). These actions, combined with the uNK cell production of chemokines CXCL10 and CXCR2, direct the migration and invasion of trophoblasts ([@b25-mmr-10-06-2851]) and promote angiogenesis in the placental bed ([@b26-mmr-10-06-2851],[@b27-mmr-10-06-2851]). The present study found similar changes in gene expression, for example, IFNGR1 transcript levels were significantly increased in co-culture systems stimulated by uNK cell-secretion medium. This concordance strongly suggests that uNK cell paracrine signaling, combined with INF-γ, regulates the expression of genes involved in embryo and trophoblast migration, endometrial decidualization and angiogenesis in human uterine endometrium.

Implantation-associated decidualization in the rat and mouse results in the accumulation of NK cells in the uterine mesometrial decidua ([@b28-mmr-10-06-2851]). uNK cells are hypothesized to be involved in pregnancy-associated uterine vascular development ([@b20-mmr-10-06-2851]). However, it is not clear how uNK cells communicate with the developing endometrial cells in order to facilitate this process. Previous *in vitro* experimentation has indicated that uNK cells produce factors that directly affect the behavior of trophoblast cells ([@b25-mmr-10-06-2851]). A number of studies have suggested that uNK cell supernatant stimulate trophoblast invasion ([@b29-mmr-10-06-2851]), whereas others have concluded that it is the uNK cell supernatants that stimulate these process ([@b20-mmr-10-06-2851]). The results of the current study indicate that the paracrine effects of uNK cells on endometrial epithelial and stromal cells mediate the development of the vasculature. Levels of ICAM-1, which is involved the migration and network formation of the trophoblast cell line ([@b15-mmr-10-06-2851]), increased significantly in this study. Thus, it is likely that ICAM-1 is involved in this paracrine network.

Although replete with cytotoxic machinery, uNK cells remain tolerant at the maternal-fetal interface ([@b26-mmr-10-06-2851]). A previous indicated that this is facilitated by VEGF-C ([@b30-mmr-10-06-2851]), and *in vitro* studies have also suggested that the involvement of IL-15 is important in promoting this tolerance ([@b17-mmr-10-06-2851]). In addition, the non-cytotoxic capacity of uNK cells is based on their ability to recognize surface MHC class I molecules on target cells, which deliver signals that suppress NK cell function. A number of studies have suggested that a lack of engagement of MHC-specific receptors leads to NK cell-mediated killing ([@b17-mmr-10-06-2851],[@b31-mmr-10-06-2851]). The results from this study showed that there was an increased expression of VEGF-C, IL-15 and MHC class I polypeptide-related sequence A/B in the co-culture systems that were treated with uNK cell-secretion medium compared with the control group, indicating similar non-cytotoxic mechanism to those already postulated. Furthermore, there is evidence that endothelial cells exhibit sensitivity to activated peripheral blood NK cells in the absence of the expression of TAP1 ([@b32-mmr-10-06-2851]), as TAP-1 is a key factor essential for peptide loading for MHC class I assembly ([@b33-mmr-10-06-2851]). It is proposed that VEGF-C is the predominant regulator of TAP1 expression in the uterus ([@b30-mmr-10-06-2851]), and the present study showed higher TAP1 expression in the uNK cell group. These findings support a dual function of VEGF-C, in which it acts as an angiogenic factor and also promotes immune tolerance in the uterine microenvironment. To the best of our knowledge, this is the first evidence that noncytotoxicity of uNK cells is directly coupled to their vascular remodeling and angiogenesis functions.

The origins of human uNK cells are not clear, and a number of mechanisms have been postulated ([@b34-mmr-10-06-2851]--[@b36-mmr-10-06-2851]). Several of the molecules that were altered by uNK cell-secretion medium in this study are known to have important functions in NK cell proliferation, including IL-15 and IL-15Rα. IL-15 has a variety of functions, including the induction of T cell proliferation and the activation of cytotoxic effector cells and monocytes ([@b37-mmr-10-06-2851],[@b38-mmr-10-06-2851]). The reciprocal interactions between uNK cells and the epithelial/stromal cell co-culture system observed in this study are similar to those in bone marrow during NK cell development. NK cells upregulate IL-15 in the bone marrow microenvironment, which is then bound and presented by IL-15Rα to the stromal cell surface, promoting increased NK cell proliferation ([@b39-mmr-10-06-2851]). These results suggest that this mechanism may occur in the endometrium in response to molecules secreted by uNK cells. The results suggest that uNK cells and non-decidualized stromal and epithelial cells may interact to maintain immune cell homeostasis in the endometrial microenvironment.

In conclusion, to the best of our knowledge, this is the first detailed study of the paracrine interaction between uNK cells and endometrial cells (epithelial/stromal cells). It indicates that this paracrine signaling may contribute to uNK cell proliferation and recruitment, embryo and trophoblast migration, endometrial decidualization, angiogenesis and immune tolerance in the uterine microenvironment.
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![Transcript levels of CXCL10, CXCL11, IL-15 and SAMD9L determined by RT-qPCR. The RT-qPCR results were consistent with those of the microarray analysis. Data are expressed as the mean ± standard error of the mean. ^\*^P\<0.01, compared with the control group. uNK, uterine natural killer cells; CXCL, chemokine (C-X-C) motif ligand; IL-15, interleukin 15; SAMD9L, sterile α motif domain containing 9-like; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.](MMR-10-06-2851-g00){#f1-mmr-10-06-2851}

![IL-15 levels in control and uNK groups. An enzyme-linked immunosorbent assay was used to measure IL-15 levels in supernatants from co-culture systems treated for 6 h with conditioned medium from decidual uNK cells or with control medium. Data are presented as the mean ±standard error of the mean. Values were corrected for the quantity of IL-15 detected in the control and uNK cell-secretion medium prior to addition to the co-culture systems. ^\*^P\<0.01, compared with the control group. IL-15, interleukin 15; uNK, uterine natural killer cells.](MMR-10-06-2851-g01){#f2-mmr-10-06-2851}

###### 

Sequences of primers for reverse transcription-quantitative polymerase chain reaction.

  Gene     Primer sequence 5′g3′           Length (bases)   Amplicon (bp)
  -------- ------------------------------- ---------------- ---------------
  CXCL10   F: CTTTCTGACTCTAAGTGGCATTC      23               176
           R: CACCCTTCTTTTTCATTGTAGCAA     24               
  CXCL11   F: TATTACTATCTGTGGTTACGGTGGAG   26               269
           R: GCACTTTTGCCAGTATCCCAT        21               
  IL-15    F: TGGCTGCTGGAAACCC             16               123
           R:CACAAGTAGCACTGGATGGAAAT       23               
  SAMD9L   F: GCCTTATCTCCACCTGTTTCTTAG     24               300
           R: TGGGATGGCATTCCTTGAC          19               
  GAPDH    F: GAGCCAAAAGGGTCATCATCT        21               231
           R: AGGGGCCATCCACAGTCTTC         20               

F, forward; R, reverse; CXCL, chemokine (C-X-C) motif ligand; IL-15, interleukin-15; SAMD9L, sterile α motif domain containing 9-like.

###### 

Upregulated transcripts altered \>2-fold.

  Gene                    Fold change   Gene ID   Description
  ----------------------- ------------- --------- -----------------------------------------------------------------------------------------
  Cytokines/ Chemokines                           
   CXCL10                 11.1          3627      Chemokine (C-X-C motif) ligand 10
   CXCL11                 4.2           6373      Chemokine (C-X-C motif) ligand 11
   IL-15                  2.6           3600      Interleukin 15
   IL-7                   2.1           3574      Interleukin 7
  Immunological factors                           
   NLRC5                  3.8           84166     NLR family, CARD domain containing 5
   FAM111A                3.4           63901     Family with sequence similarity 111, member A
   ACTR2                  2.6           10097     ARP2 actin-related protein 2 homolog (yeast)
   HSPH1                  2.2           10808     Heat shock protein 1
   IFIT5                  2.2           24138     Interferon-induced protein with tetratricopeptide repeats 5
   UVRAG                  2.1           7405      UV radiation resistance associated gene
  Apoptotic protein                               
   RASSF6                 2.2           166824    Ras association (RalGDS/AF-6) domain family member 6
  Tryptophan metabolism                           
   IDO1                   3.6           3620      Indoleamine 2,3-dioxygenase 1
  Signaling factors                               
   GBP2                   3.2           2634      Guanylate binding protein 2, interferon-inducible
   UACA                   3.1           55075     Uveal autoantigen with coiled-coil domains and ankyrin repeats
   IFIT3                  2.8           3437      Interferon-induced protein with tetratricopeptide repeats 3
   ALCAM                  2.8           214       Activated leukocyte cell adhesion molecule
   CGA                    2.6           1081      Glycoprotein hormones, α polypeptide
   EDNRA                  2.5           1909      Endothelin receptor type A
   WASF2                  2.2           10163     WAS protein family, member 2
   IL6ST                  2.1           3572      Interleukin 6 signal transducer
   USP15                  2.1           9958      Ubiquitin specific peptidase 15
   MIER1                  2.1           57708     Mesoderm induction early response 1 homolog
   RGS12                  2.0           6002      Regulator of G-protein signaling 12
  Transcription                                   
   STAT1                  3.7           6772      Signal transducer and activator of transcription 1
   IRF1                   3.6           3659      Interferon regulatory factor 1
   IRF9                   3.2           10379     Interferon regulatory factor 9
   IFI16                  3.2           3428      Interferon, γ-inducible protein 16
   ATRX                   3.1           546       Alpha thalassemia/mental retardation syndrome X-linked
   TCERG1                 2.5           10915     Transcription elongation regulator 1
   ZNF644                 2.4           84146     Zinc finger protein 644
   ZEB1                   2.2           6935      Zinc finger E-box binding homeobox 1
   SAFB2                  2.1           9667      Scaffold attachment factor B2
   PRDM2                  2.1           7799      PR domain containing 2
  Nucleotide metabolism                           
   NUFIP2                 3.0           57532     Nuclear fragile X mental retardation protein interacting protein 2
   PAPOLA                 2.2           57532     Poly(A) polymerase alpha
   EIF4G1                 2.3           10914     Eukaryotic translation initiation factor 4γ, 1
   CRCP                   2.5           1981      CGRP receptor component
   AGGF1                  2.6           27297     Angiogenic factor with G patch and FHA domains 1
   XRN2                   2.1           55109     5′-3′ exoribonuclease 2
  Enzyme activity                                 
   GBP4                   6.8           115361    Guanylate binding protein 4
   GBP5                   4.8           115362    Guanylate binding protein 5
   INPP4B                 4.8           8821      Inositol polyphosphate-4-phosphatase, type II
   GBP7                   4.7           388646    Guanylate binding protein 7
   SETD2                  4.2           29072     SET domain containing 2
   GBP1                   3.9           2633      Guanylate binding protein 1
   PSMB9                  3.3           5698      Proteasome (prosome, macropain) subunit, β type, 9
   WASL                   3.3           8976      Wiskott-Aldrich syndrome-like
   PUS7L                  3.0           83448     Pseudouridylate synthase 7 homolog-like
   C1R                    2.9           715       Complement component 1
   TAP1                   2.8           6890      Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
   FAF2                   2.7           23197     Fas associated factor family member 2
   UBE2L6                 2.7           9246      Ubiquitin-conjugating enzyme E2L 6
   PARP14                 2.7           54625     Poly (ADP-ribose) polymerase family, member 14
   PARP9                  2.7           83666     Poly (ADP-ribose) polymerase family, member 9
   PSME4                  2.5           23198     Proteasome (prosome, macropain) activator subunit 4
   OTUD4                  2.5           54726     OTU domain containing 4
   BIRC6                  2.4           57448     Baculoviral IAP repeat containing 6
   ARHGAP21               2.4           57584     Rho GTPase activating protein 21
   DTX3L                  2.4           151636    Deltex 3-like
   RARRES3                2.3           5920      Retinoic acid receptor responder 3
   MGEA5                  2.3           10724     Meningioma expressed antigen 5
   DCAF8                  2.3           50717     DDB1 and CUL4 associated factor 8
   GPD2                   2.3           2820      Glycerol-3-phosphate dehydrogenase 2
   UHMK1                  2.3           127933    U2AF homology motif (UHM) kinase 1
   PDP1                   2.2           54704     Pyruvate dehyrogenase phosphatase catalytic subunit 1
   USP10                  2.2           9100      Ubiquitin specific peptidase 10
   COIL                   2.2           8161      Coilin
   UFL1                   2.2           23376     UFM1-specific ligase 1
   USP1                   2.1           7398      Ubiquitin specific peptidase 1
   G2E3                   2.1           55632     G2/M-phase specific E3 ubiquitin protein ligase
   NF1                    2.0           4763      Neurofibromin 1
   PHACTR2                2.0           9749      Phosphatase and actin regulator 2
  Transporters                                    
   TPR                    4.4           7175      Translocated promoter region, nuclear basket protein
   APOL6                  3.2           80830     Apolipoprotein L, 6
   GCC2                   2.8           9648      GRIP and coiled-coil domain containing 2
   APOL3                  2.4           80833     Apolipoprotein L, 3
   CPNE3                  2.4           8895      Copine III
   USO1                   2.2           8615      USO1 vesicle docking protein homolog
   SLC38A1                2.2           81539     Solute carrier family 38, member 1
   NIPAL1                 2.1           152519    NIPA-like domain containing 1
   KIAA1033               2.1           23325     KIAA1033
   NUPL1                  2.1           9818      Nucleoporin like 1
  Structural factors                              
   MIS18BP1               3.9           55320     MIS18 binding protein 1
   CDC27                  3.3           996       Cell division cycle 27 homolog
   CALD1                  3.1           800       Caldesmon 1
   LIMA1                  3.0           51474     LIM domain and actin binding 1
   SLMAP                  2.7           7871      Sarcolemma associated protein
   TLN1                   2.7           7094      Talin 1
   EZR                    2.5           7430      Ezrin
   ITGB1                  2.5           3688      Integrin, β1
   APPL1                  2.5           26060     Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
   RTP4                   2.5           64108     Receptor (chemosensory) transporter protein 4
   WAPAL                  2.4           23063     Wings apart-like homolog
   PRRC2C                 2.4           23215     Proline-rich coiled-coil 2C
   CASC5                  2.4           57082     Cancer susceptibility candidate 5
   ENC1                   2.3           8507      Ectodermal-neural cortex 1
   KIF14                  2.2           9928      Kinesin family member 14
   SPTBN1                 2.2           6711      Spectrin, β, non-erythrocytic 1
   MYO6                   2.2           4646      Myosin VI
   ODF2L                  2.1           57489     Outer dense fiber of sperm tails 2-like
   DYNC1H1                2.1           1778      Dynein, cytoplasmic 1, heavy chain
   PPP4R2                 2.1           151987    Protein phosphatase 4, regulatory subunit 2
   SRPR                   2.0           6734      Signal recognition particle receptor
  Kinase                                          
   WNK1                   4.0           65125     WNK lysine deficient protein kinase 1
   PRKDC                  3.5           5591      Protein kinase, DNA-activated, catalytic polypeptide
   IQGAP1                 3.0           8826      IQ motif containing GTPase activating protein 1
   CMPK2                  2.8           129607    Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial
   BAZ1B                  2.7           9031      Bromodomain adjacent to zinc finger domain, 1B
   CCND2                  2.6           894       Cyclin D2
   MOB1A                  2.5           55233     MOB kinase activator 1A
   MAP4K5                 2.5           11183     Mitogen-activated protein kinase kinase kinase kinase 5
  Ion binding proteins                            
   DSC2                   4.5           1824      Desmocollin 2
   EEA1                   4.2           8411      Early endosome antigen 1
   ZC3H11A                3.3           9877      Zinc finger CCCH-type containing 11A
   CLSTN1                 2.8           22883     Calsyntenin 1
   C1S                    2.7           716       Complement component 1, s subcomponent
   THAP6                  2.6           152815    THAP domain containing 6
   RSAD2                  2.5           91543     Radical S-adenosyl methionine domain containing 2
   ZNFX1                  2.3           57169     Zinc finger, NFX1-type containing 1
   PLCB4                  2.2           5332      Phospholipase C, β4
   TIPARP                 2.2           25976     TCDD-inducible poly(ADP-ribose) polymerase
   WDFY1                  2.1           57590     WD repeat and FYVE domain containing 1
   CHURC1                 2.1           91612     Churchill domain containing 1
   ITGA4                  2.1           3676      Integrin, α4
   XAF1                   2.1           54739     XIAP associated factor 1
  DNA/RNA proteins                                
   ZFR                    4.4           51663     Zinc finger RNA binding protein
   TOP1                   4.2           7150      Topoisomerase (DNA) I
   BOD1L1                 3.4           259282    Biorientation of chromosomes in cell division 1-like 1
   IFIT2                  3.3           3433      Interferon-induced protein with tetratricopeptide repeats 2
   CENPF                  3.1           1063      Centromere protein F, 350/400 kDa (mitosin)
   MBNL1                  3.0           4154      Muscleblind-like splicing regulator 1
   DHX9                   2.4           1660      DEAH (Asp-Glu-Ala-His) box polypeptide 9
   FMR1                   2.4           2332      Fragile X mental retardation 1
   DDX58                  2.3           23586     DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
   BCLAF1                 2.3           9774      BCL2-associated transcription factor 1
   DNMT1                  2.2           1786      DNA (cytosine-5-)-methyltransferase 1
   NOL8                   2.2           55035     Nucleolar protein 8
   RNF213                 2.2           57674     Ring finger protein 213
   BDP1                   2.2           55814     B double prime 1
   RAD21                  2.2           5885      RAD21 homolog
   HP1BP3                 2.1           50809     Heterochromatin protein 1, binding protein 3
   SF3B1                  2.0           23451     Splicing factor 3b, subunit 1
  Other                                           
   SAMD9L                 5.7           219285    Sterile α motif domain containing 9-like
   C10orf118              5.5           55088     Chromosome 10 open reading frame 118
   MTUS1                  2.7           57509     Microtubule associated tumor suppressor 1
   EPSTI1                 2.6           94240     Epithelial stromal interaction 1
   ATXN7L3B               2.6           552889    Ataxin 7-like 3B
   ANKRD32                2.5           84250     Ankyrin repeat domain 32
   EHBP1                  2.4           23301     EH domain binding protein 1
   PPFIBP1                2.4           8496      PTPRF interacting protein, binding protein 1 (liprin β1)
   TMTC3                  2.3           160418    Transmembrane and tetratricopeptide repeat containing 3
   CEP350                 2.2           9857      Centrosomal protein 350 kDa
   BTBD10                 2.2           84280     BTB (POZ) domain containing 10
   BTN3A3                 2.1           10384     Butyrophilin, subfamily 3, member A3
   KCTD9                  2.1           54793     Potassium channel tetramerisation domain containing 9

Gene transcription in co-culture systems following stimulation with uNK cell-secretion medium using a GeneChip PrimeView Human Gene Expression Array. P\<0.001, compared with control group. Upregulated genes: 155 transcripts. uNK, uterine natural killer cells.
